Strides Arcolab to raise up to Rs 1,500 crore through market instruments
It added: "The fund raising is subject to shareholders' approval and such other statutory approvals as may be required including that of Foreign Investment Promotion Board."

It added: "The fund raising is subject to shareholders' approval and such other statutory approvals as may be required including that of Foreign Investment Promotion Board."
Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India to Strides Arcolab for Rs 165 crore.
The acquisition included access to the product pipeline that was under development by Aspen and a number of major product launches slated for the next six months.
The product will be manufactured at the company's oral dosage facility at Bengaluru and marketed by the company in the US, it added.
Alivira Animal Health, a joint venture of Sequent Scientific and Shasun Pharmaceuticals, is set to buy the veterinary business of Mumbai-based Lyka Labs
Strides Arcolab plans to approach Foreign Investment Promotion Board (FIPB) after the government rejected its proposal to issue shares to non-resident and resident equity shareholders of Shasun Pharmaceuticals.
Torrent Pharmaceuticals' proposal for increasing FII investment limit to 35 per cent from 13.09 per cent was the biggest in terms of value approved by the government.
Strides Arcolab has said its deal with Aspen Pharmacare to buy the latter's Australia assets will help the Indian drug company rebuild its business.
Strides Arcolab said it has received approval from the United States Food & Drug Administration (USFDA) for Lamivudine and Zidovudine tablets to treat HIV infection.
Bangalore-based Strides Arcolab said US health regulator has approved its drug used for treating HIV infection in adult and children for sale in US market.
grams of sodium bicarbonate and 1.48 grams of potassium per 4.